Skip to main content
Premium Trial:

Request an Annual Quote

Three to Grow on from Nature Biotechnology

The current issue of Nature Biotechnology includes a paper by scientists at the Institute for Regenerative Medicine at Wake Forest who discovered another possible source for stem cells: placenta and amniotic fluid. The researchers published their findings and describe the amniotic fluid-derived stem cells as somewhere between embryonic and adult stems cells in development.

In another paper, researchers at the University of Texas at Austin have reported a method for large-scale absolute protein expression measurements. The method was used to estimate the relative contributions of transcriptional and translational-level gene regulation in the yeast and E. coli proteomes.

Last but not least, a paper from William Poueymirou of Regeneron Pharmaceuticals and colleagues presents an approach using genetically modified stem cells to rapidly generate mutant mice for the exploration of gene function.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.